Andreas Ullern

  • PhD student; MD
  • 91195324
 

Publications 2026

Ullern A, Garborg KK, Chauhan SK, Holm K, Bang C, Dunn C, Johnsen PH, Hov JER, Kyte JA (2026)
Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial
J Immunother Cancer, 14 (7)
DOI 10.1136/jitc-2026-015122, PubMed 42476727

Publications 2025

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol, 20 (2), 511-523
DOI 10.1002/1878-0261.70117, PubMed 40852937

Publications 2024

Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA (2024)
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer
Mol Oncol, 19 (4), 1229-1243
DOI 10.1002/1878-0261.13760, PubMed 39545921

Scroll to top